> Back to EJC

Recent editions

  • October 2015
    Milena Sant on the latest results from the EUROCARE study.
  • September 2015
    The science behind the IARC code that could reduce cancer in Europe.
  • July/August 2015
    Thomas Helleday on an exciting new class of drug, MTH1 inhibitors.
  • June 2015
    Lesley Seymour and Jan Bogaerts on the future of RECIST.
  • May 2015
    Paul Workman on strategies for overcoming resistance to new drugs.
  • April 2015
    Highlights from the TAT Congress in Paris.
  • March 2015
    Christopher Wild on the exposome, a measure of environmental exposure.
  • February 2015
    Mathematicians are developing a blood flow model for metastasis.
  • January 2015
    René Bernards on discovering effective drug combinations.
  • December 2014
    Research on the high rate of burnout among young oncologists.
  • November 2014
    Carl June on the efficacy of CAR-T cells in treating leukaemia.

> All 2014 Editions

> All 2013 Editions

> All 2012 Editions

> All 2011 Editions

EJC News Focus – January 2013

Loading EJC News Focus video

Predictions in Cancer for 2013

What will be the big news in your field in 2013? The availability of new drugs, perhaps? Long awaited phase III data which could set research on a new tack? Or the spiralling costs that will effectively block patients’ access to new treatment approaches? In this month’s EJC News Focus, Helen Saul asks Mary O’Brien, Richard Marais, Roger Stupp, Manuela Schmidinger and David Cameron what they expect to be the key issues in their field in the coming year.